Blackmores Limited (ASX:BKL) describes itself as Australia’s leading natural health company. Maurice Blackmore founded the company in the 1930s. Blackmores has a number of different brands, not just the well-recognised Blackmores brand. It operates BioCeuticals, the Blackmores Institute, Fusion Health & Oriental Botanicals, Impromy, IsoWhey and Pure Animal Wellbeing (PAW).
The Blackmores Ltd (ASX: BKL) share price has been in decline since December of 2015, and has lagged the rally in the S&P/ASX 200 (ASX: XJO) from the low in March this year
Blackmores Limited (ASX:BKL) shares have fallen after the vitamin business revealed its FY20 result.
Here’s what Victoria’s COVID-19 clamp-down means for JB Hi-Fi Limited (ASX: JBH), Inghams Group Ltd (ASX: ING) and Blackmores Limited (ASX: BKL) shares.
Blackmores (ASX:BKL) has announced that it is going to do a capital raising of up to $117 million.
The Australian share market and global stock markets have been rattled by concerns of the Coronavirus outbreak.
the All Ordinaries (ASX: XAO) was trading 0.49% higher, with shares of Blackmores Limited (ASX:BKL), Idp Education Ltd (ASX:IEL) and Carsales.Com Ltd (ASX:CAR) moving the Australian share market.
AMCOR PLC/IDR UNRESTR (ASX: AMC) delivered its half-year financial report. Amcor (AMC) shares traded up 0.65%.
The Blackmores Limited (ASX:BKL) share price was trading 17% lower today after the ASX’s open after the vitamin company emerged from a trading halt with a disappointing trading update.
Here’s today’s S&P/ASX 200 (ASX: XJO) news. Blackmores Ltd (ASX:BKL) emerges from a trading halt, Evolution Ltd (ASX:EVN) and Amcor Ltd (ASX:AMC) deliver half-year reports.
